ANN D. RHOADS - 17 Jun 2021 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Role
Director
Signature
/s/ Michel Detheux, as Attorney-in-Fact
Issuer symbol
ITOS
Transactions as of
17 Jun 2021
Net transactions value
$0
Form type
4
Filing time
21 Jun 2021, 20:17:14 UTC
Previous filing
20 May 2021
Next filing
31 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITOS Stock Option (Right to Buy) Award $0 +16,608 $0.000000 16,608 17 Jun 2021 Common Stock 16,608 $26.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest and become exercisable in full upon the earlier to occur of (a) June 17, 2022 or (b) the next annual meeting of the Issuer's stockholders.